Arsenal’s deal for Hopebridge valued at ~$255 mln


healthcare, autism, private equity, M&A, behavioral health, ABA
KatarzynaBialasiewicz/iStock/Getty Images
Arsenal Capital Partners’ all-cash purchase of a majority stake in Hopebridge assigns the Indianapolis autism treatment-services company an enterprise value of some $255 million, Buyouts has learned. Representing the latest in a flurry of deals in behavioral health, New York’s Arsenal ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.